Trends in Hospital Inpatient Drug Costs: Issues and Challenges

October 11, 2016

AHA also released an infographic outlining how rising drug prices are hurting hospitals and potentially limiting access to care for patients.

Key Resources

Related Resources

Special Bulletin
White House Releases Executive Orders Aimed at Addressing High Drug Prices
Public
President Trump yesterday signed an additional executive order aimed at lowering the price of prescription drugs. Three executive orders were signed in July…
Action Alert
Urge your Representatives to Sign on to ‘Dear Colleague’ Letter on 340B Contract Pharmacy Issue
Member
In response to recent actions taken by a number of drug companies to limit the distribution of certain 340B drugs to hospitals and health systems, Reps. Diana…
Letter/Comment
AHA Again Urges HHS to Protect 340B Program From Drug Companies’ Actions
Public
AHA to HHS again expressing concern with recent actions taken by several major drug manufacturers to limit the distribution of certain 340B drugs to our…
Letter/Comment
AHA Urges HHS to Take Action Against Drug Manufacturers for Limiting the Distribution of 340B Drugs
Public
AHA expresses concern regarding recent action taken by three major drug manufacturers – Eli Lilly and Co., Merck and Sanofi – to limit the distribution of…
Special Bulletin
White House Releases Executive Orders Aimed at Addressing High Drug Prices
Public
President Trump today signed three executive orders aimed at lowering the price of prescription drugs. The first executive order seeks to pass federally-…
Letter/Comment
AHA Letter to CMS on Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid
July 20, 2020 The Honorable Seema Verma Administrator Centers for Medicare & Medicaid Services Hubert H. Humphrey Building 200 Independence Avenue, S.W.,…